Amniotic Stem Cell Therapy in California
R3 Stem Cell California brings over a decade of global regenerative medicine experience to patients across Northern and Southern California. Learn who we are, what we do, and why it matters.
WHAT IS AMNIOTIC STEM CELL THERAPY?
Amniotic stem cell therapy is a minimally invasive, outpatient regenerative procedure that uses processed tissue derived from donated amniotic membranes — obtained ethically from consenting donors during planned cesarean deliveries. The tissue contains growth factors, cytokines, hyaluronic acid, and other signaling proteins that may support the body’s natural tissue repair process.
Unlike PRP or bone marrow procedures, amniotic therapy does not use material from the patient’s own body. The procedure is nonsteroidal and does not require general anesthesia. At R3 Stem Cell California, it is one of four regenerative procedures offered to patients across the state
Note on experimental status: Amniotic stem cell therapy for orthopedic and musculoskeletal conditions is considered investigational by the FDA and is not FDA-approved for these indications. The amniotic tissue products used are regulated under FDA tissue bank guidelines (21 CFR Part 1271). R3 Stem Cell California discloses this to every patient as part of the consultation process.
Top 5 Benefits of Amniotic Stem Cell Therapy for Arthritis
Amniotic stem cell therapy is quickly becoming popular among people because it has the ability to resolve a lot of problems that occur due to old age and the overuse of muscles, bones and ligaments. The wonderful elements in amniotic fluid such as growth factors as well as the stem cells are excellent at repairing most orthopedic symptoms experienced by arthritis patients.
Arthritis is a serious disorder of the joints where a patient can suffer from strong inflammation in a number of joints which may be present in the different areas of the body. Arthritis may happen due to a number of reasons such as from a degenerative joint, trauma and simply old age. Infections can also cause the swelling of joints and bring about arthritis.
Here, we will present the top five benefits that can be gained when employing amniotic stem cell therapy for arthritis patients.
Regenerates Tendons and Ligaments
Arthritis usually damages the tendons and ligaments present around an affected joint. This causes intense pain due to increased pressure on the joint. Amniotic stem cell therapy is able to regenerate these damaged bone and muscle connectors which in turn reduce the pressure on the joint, lowering pain and inflammation.
Reduces Inflammation
Amniotic fluid contains many natural anti-inflammatory chemicals. This means that amniotic stem cell therapy actively reduces the joint inflammation of a person suffering from arthritis. This greatly reduces the intense symptoms of the disease allowing patients to take on other physical therapies for quick relief.
Longer Pain Relief
Amniotic stem cell therapy is able to provide a long term solution to arthritis patients. This therapy works directly on affected joints, and is therefore able to work in a much more progressive manner. This therapy provides longer pain relief when compared to the older treatments.
Growth Factors Help
We should remember that amniotic fluid is full of growth factors. These growth factors are important for the growth of the baby in the womb and have the ability to accelerate cell growth in damaged joints due to arthritis. These growth factors naturally help the damaged tissues at the site of a swollen joint to recover by growing new cells.
In addition, the growth factors are crucial for several reasons, such as activating the body's stem cells to come into the area for repair as well.
Effects on the Bone and Cartilage
Scientists are still researching the effects of amniotic stem cell therapy on the bones and cartilage, but there is a common belief among orthopedic researchers that this therapy greatly improves the cartilage tissue and even repairs it along with tendon and ligament tissue as well. This means that this therapy can stop the degradation of cartilage of an arthritis patient, and ensure that such people can improve their locomotion due to healthier bones and joints. Amniotic stem cell therapy can even generate new tissues in the joints, which means that it can cure the symptoms of most types of arthritis.
Amniotic stem cell therapy is free from the ethical debates of embryonic stem cells and allows a new way of resolving different medical issues that especially occur due to the overuse of our body.
CONDITIONS WE ADDRESS
Patients across California come to R3 Stem Cell California with a wide range of musculoskeletal and orthopedic concerns. During your consultation, your provider can discuss whether amniotic stem cell therapy is appropriate for your specific situation. Commonly discussed conditions include:
- Knee arthritis and cartilage wear
- Hip joint pain and stiffness
- Shoulder pain and rotator cuff conditions
- Lower back and lumbar spine discomfort
- Cervical (neck) stiffness and pain
- Tennis elbow and golfer's elbow
- Achilles tendon and plantar fascia concerns
- Ligament sprains and tendonitis
- Bursitis (hip, shoulder, knee)
- SI joint inflammation and facet syndrome
- Spinal arthritis
- Wrist, hand, ankle, and foot joint pain
This list is not exhaustive. If your condition is not listed, ask at your free consultation.
Not Sure If Amniotic Stem Cell Therapy Is Right for You?
That is exactly what the free consultation is for. Your R3 Stem Cell California provider will review your condition, answer your questions honestly, and give you a clear recommendation — with no obligation to proceed.
FREQUENTLY ASKED QUESTIONS
At R3 Stem Cell California, amniotic stem cell therapy is used for musculoskeletal and orthopedic conditions including joint arthritis (knee, hip, shoulder), tendonitis, ligament sprains, bursitis, cartilage defects, spinal arthritis, SI joint inflammation, and soft tissue injuries. Your provider will confirm whether your specific condition is a candidate during your free consultation.
The tissue used in amniotic stem cell therapy is sourced from amniotic membranes donated by consenting mothers during planned cesarean deliveries. No embryos are used and no harm comes to the mother or baby. The tissue is processed and screened according to FDA tissue bank regulations before use.
No. Amniotic stem cell therapy uses tissue from the amniotic membrane — not embryos. It does not involve embryonic stem cells and carries none of the ethical concerns associated with embryonic research. This distinction is important and often misunderstood.
Amniotic stem cell therapy for orthopedic and musculoskeletal conditions is considered investigational by the FDA and is not FDA-approved for these indications. R3 Stem Cell California discloses this clearly before any procedure is recommended or scheduled. The amniotic tissue products used are regulated under FDA tissue bank guidelines (21 CFR Part 1271).
PRP and bone marrow procedures use material drawn from the patient's own body (autologous). Amniotic therapy uses donated allograft tissue. All three are minimally invasive and outpatient, but the source material and processing are different. Your R3 Stem Cell California provider will explain which option is most appropriate for your condition at your consultation.
Candidates are typically patients with joint arthritis, tendon or ligament injuries, cartilage wear, or soft tissue conditions who want a non-surgical, nonsteroidal alternative. Patients who are not surgical candidates, who want to explore options before surgery, or who have not responded adequately to cortisone or other conservative treatments are often evaluated for this procedure. Suitability is determined at the consultation — not assumed in advance.
Amniotic stem cell therapy is an outpatient procedure. Most visits, from preparation through injection, take approximately 30 to 60 minutes. Patients do not require general anesthesia and typically return to light daily activity the same day or the following day.
R3 Stem Cell California has affiliated provider locations across both Northern and Southern California, including cities in the Bay Area, Sacramento region, Orange County, and San Diego. Call (844) GET-STEM or use the contact form on this site to find the nearest provider and schedule a free consultation.
The cost varies depending on the area being treated, the volume of product used, and the specific provider location. Most regenerative procedures — including amniotic therapy — are not covered by insurance and are an out-of-pocket expense. R3 Stem Cell California offers financing options and provides transparent cost information at the consultation with no obligation to proceed.
R3 Stem Cell is the only US company to have achieved Institutional Review Board (IRB) approval for investigating regenerative therapies with amniotic and umbilical cord tissue across multiple condition categories. This research is registered publicly on ClinicalTrials.gov. While results vary and the therapy remains investigational, the R3 network brings a depth of real-world clinical experience — over 29,000 procedures globally — that few regenerative medicine providers can match.